Stratos Wealth Partners »

Acasti Pharma shares owned by Stratos Wealth Partners

Quarter-by-quarter ownership of Acasti Pharma (GRCE) shares owned by Stratos Wealth Partners from 13F filings

Historical chart of Stratos Wealth Partners investment in Acasti Pharma

Tip: Access up to 7 years of quarterly data

All positions including Acasti Pharma held by Stratos Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acasti Pharma by Stratos Wealth Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $39k 11k 3.46

More positions owned by Stratos Wealth Partners

Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core Msci Intl (IDEV)
Spdr Series Trust State Street Spd (SPLG)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Stratos Wealth Partners

Top funds holding Acasti Pharma

Nantahala Capital Management
AIGH Capital Management
Vanguard Group
ADAR1 Capital Management
Stonepine Capital Management
Renaissance Technologies
Citadel Advisors
Millington Financial Advisors
Stratos Wealth Partners
National Bank Of Canada /fi/
Tower Research Capital
Royal Bank of Canada
Activest Wealth Management
SBI Securities
Steward Partners Investment Advisory

View all funds holding Acasti Pharma